S S Hecht1. 1. University of Minnesota Cancer Center, Mayo Mail Code 806, 420 Delaware Street SE, Minneapolis, MN 55455, USA. hecht002@umn.edu
Abstract
OBJECTIVE: To review the literature on carcinogen derived biomarkers of exposure to secondhand tobacco smoke (SHS). These biomarkers are specifically related to known carcinogens in tobacco smoke and include urinary metabolites, DNA adducts, and blood protein adducts. METHOD: Published reviews and the current literature were searched for relevant articles. RESULTS: The most consistently elevated biomarker in people exposed to SHS was 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) and its glucuronides (NNAL-Gluc), urinary metabolites of the tobacco specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). The tobacco specificity of this biomarker as well as its clear relation to an established lung carcinogen are particularly appropriate for its application in studies of SHS exposure. CONCLUSION: The results of the available carcinogen derived biomarker studies provide biochemical data which support the conclusion, based on epidemiologic investigations, that SHS causes lung cancer in non-smokers.
OBJECTIVE: To review the literature on carcinogen derived biomarkers of exposure to secondhand tobacco smoke (SHS). These biomarkers are specifically related to known carcinogens in tobacco smoke and include urinary metabolites, DNA adducts, and blood protein adducts. METHOD: Published reviews and the current literature were searched for relevant articles. RESULTS: The most consistently elevated biomarker in people exposed to SHS was 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) and its glucuronides (NNAL-Gluc), urinary metabolites of the tobacco specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). The tobacco specificity of this biomarker as well as its clear relation to an established lung carcinogen are particularly appropriate for its application in studies of SHS exposure. CONCLUSION: The results of the available carcinogen derived biomarker studies provide biochemical data which support the conclusion, based on epidemiologic investigations, that SHS causes lung cancer in non-smokers.
Authors: B Pignatelli; C Q Li; P Boffetta; Q Chen; W Ahrens; F Nyberg; A Mukeria; I Bruske-Hohlfeld; C Fortes; V Constantinescu; H Ischiropoulos; H Ohshima Journal: Cancer Res Date: 2001-01-15 Impact factor: 12.701
Authors: Stephen E Wilson; Glenn Talaska; Robert S Kahn; Brenda Schumann; Jane Khoury; Anthony C Leonard; Bruce P Lanphear Journal: Int Arch Occup Environ Health Date: 2010-03-25 Impact factor: 3.015
Authors: Rachel I Vogel; Steven G Carmella; Irina Stepanov; Dorothy K Hatsukami; Stephen S Hecht Journal: Biomarkers Date: 2011-08-03 Impact factor: 2.658
Authors: Katherine A Moon; Ana M Rule; Hoda S Magid; Jacqueline M Ferguson; Jolie Susan; Zhuolu Sun; Christine Torrey; Salahaddin Abubaker; Vladimir Levshin; Asli Çarkoglu; Ghada Nasr Radwan; Maha El-Rabbat; Joanna E Cohen; Paul Strickland; Patrick N Breysse; Ana Navas-Acien Journal: Nicotine Tob Res Date: 2018-03-06 Impact factor: 4.244
Authors: Irina Stepanov; Pramod Upadhyaya; Steven G Carmella; Rachel Feuer; Joni Jensen; Dorothy K Hatsukami; Stephen S Hecht Journal: Cancer Epidemiol Biomarkers Prev Date: 2008-07 Impact factor: 4.254
Authors: Peyton Jacob; Christopher Havel; Do-Hoon Lee; Lisa Yu; Mark D Eisner; Neal L Benowitz Journal: Anal Chem Date: 2008-10-08 Impact factor: 6.986
Authors: Timothy R Church; Kristin E Anderson; Neil E Caporaso; Mindy S Geisser; Chap T Le; Yan Zhang; Adam R Benoit; Steven G Carmella; Stephen S Hecht Journal: Cancer Epidemiol Biomarkers Prev Date: 2009-01 Impact factor: 4.254